-
Related Journals in Neuroscience
-
Lost in translation—what is translational neuroscience research?
-
Call for Paper: Covid-19 in Basic and Clinical Neuroscience
-
Active Ingredients in Digital Cognitive Interventions: Integrating Dismantling Designs With Mechanistic Neuroscience
-
Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results
-
Diagnostic Agreement and 1‐Year Outcomes in Functional Neurological Disorder Following Neuroscience‐Informed Assessment, Education, and Counseling: A Retrospective Cohort Study
-
Perampanel as add‐on in high‐grade glioma–related epilepsy: Seizure control and QoL in a prospective, multicenter, real‐world 6‐month follow‐up study
-
Mapping of Subjective Accounts into Interpreted Clusters (MOSAIC): Topic Modelling and LLM applied to Stroboscopic Phenomenology
-
Evaluating the Clinical Utility of the Interpersonal Hopelessness Scale Among Adults With Past‐Year Suicide Ideation
-
Clinical Neuropsychiatry Volume 22, issue 6 – December 2025
-
Clinical Neuropsychiatry Volume 21, issue 6 – December 2024
-
Human herpesvirus 6A and other risk factors for multiple sclerosis
-
Sex differences in neural stress responses over psychosocial stress exposure
-
Toxic Effects of Excess Vitamins A, B6, and Folic Acid on the Nervous System
-
A Case of Voltage-Gated Calcium Channel and TG6 Antibody–Positive Cerebellar Ataxia
-
Peripheral Blood Regulatory T Cells and IL-6 are Associated with Cognitive Impairment After Acute Ischemic Stroke
-
Three key lessons learned from over a decade of gaming disorder assessment research
-
Environmental enrichment applied during epileptogenesis increases seizure latency and reduces serum interleukin-6 in a PTZ kindling model
-
Clinical Characteristics of Over‐The‐Counter Drug Misusers in Psychiatric Practice in Japan: Comparison by Type of Drug Misused for the First Time
-
Predicting moments of impaired control over addictive behaviors: Relevance of craving and inhibitory control measured in laboratory and ambulatory settings
-
Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study
-
Correction: Real‑World Response and Super‑Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study
-
N-Glycosylation of mGluR6 Modulates Receptor Cell-Surface Transport, G-Protein Coupling, and Interactions With Synaptic Adhesion Molecules
-
Curcumin and an antioxidant formulation protect C57BL/6J mice from MPTP-induced Parkinson’s disease like changes: potential neuroprotection for neurodegeneration
